Results 161 to 170 of about 20,060 (180)

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

Nature Genetics, 2009
Yasuhito Tanaka, Naoya Sakamoto, Mina Nakagawa   +2 more
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Pawel Kalinski, Soldano Ferrone   +2 more
exaly  

[Long-acting interferon: studies on pegylated interferon].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002
Hui, Ma, Hao, Wang
openaire   +1 more source

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

The Lancet Gastroenterology and Hepatology, 2017
Victor Pantea, Valentin Cebotarescu, Lilia Cojuhari   +2 more
exaly  

[Peg-interferon or pegylated interferon].

Revue de l'infirmiere, 2003
openaire   +1 more source

Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin

Gastroenterology, 2010
Josephine H Li, Sunil Suchindran, Xiang Q Lao   +2 more
exaly  

Pegylated interferons α2a and α2b in the treatment of chronic hepatitis C

Nature Reviews Gastroenterology and Hepatology, 2010
Alessio Aghemo, Massimo Colombo
exaly  

Interferon and Cancer Treatment

Ca-A Cancer Journal for Clinicians, 1978
exaly  

Interferon

Ca-A Cancer Journal for Clinicians, 1972
exaly  

Interferon and liposome pegylation

2007
CATTEL, Luigi, MILLA, Paola
openaire   +1 more source